5-amino-1MQ acts as an inhibitor of an enzyme called NNMT that degrades a nicotinamide adenine dinucleotide (NAD+) precursor called nicotinamide, which is also a precursor of nicotinamide mononucleotide (NMN)
Mitochondrial support: Enhances mitochondrial respiration and reduces reactive oxygen species, at least in aging fibroblast models
The combination of Cartalax, TB-500, and BPC-157 enables investigation of pathway convergence, signaling overlap, and coordinated molecular responses within controlled experimental models
Due to their robust inorganic matrix, they are especially suitable for delivering fragile bioactive molecules such as biomolecular drugs
--- Dosing Guidelines NMN (nicotinamide mononucleotide) Standard dose: 250500mg daily Timing: morning with food is fine
Rotate injection sites to prevent lipohypertrophy (fat tissue hardening)